Market Tracker

04/17 6:05pm ET

Repros Therapeutics Inc (NASDAQ:RPRX)

15.98
Data as of Apr 17
 +0.28 / +1.78%
Today’s Change
13.93
Today|||52-Week Range
29.79
-12.68%
Year-to-Date

Today’s Trading

Previous close15.70
Today’s open15.60
Day’s range15.36 - 16.23
Volume175,468
Average volume (3 months)386,036
Market cap$352.7M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-12.71%
Earnings growth (this year)-10.83%
Earnings growth (next 5 years)-39.88%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.67

Competitors

 Today’s
change
Today’s
% change
SNTASynta Pharmaceutical...-0.07-1.73%
SNSSSunesis Pharmaceutic...-0.02-0.39%
FLMLFlamel Technologies ...+0.66+6.23%
SUPNSupernus Pharmaceuti...+0.07+0.85%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 19, 2014
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$0.00
Annual profit (last year)-$27.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts